{
  "paper_metadata": {
    "pmid": "30829617",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Endemic populations in Portugal, Japan, and Sweden",
        "phenotype": "Peripheral neuropathy, cardiomyopathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 8,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 80.0,
        "age_dependent_penetrance": [
          {
            "age_range": "20-40 years",
            "penetrance_percentage": 80.0,
            "carriers_in_range": 10,
            "affected_in_range": 8
          },
          {
            "age_range": "60+ years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 10,
            "affected_in_range": 5
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 30,
          "age_at_onset": 25,
          "age_at_diagnosis": 28,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Length-dependent, painful, small-fibre neuropathy",
          "evidence_sentence": "V30M is the most common ATTR mutation worldwide and is endemic in Portugal, Japan and Sweden."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 62,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms observed",
          "evidence_sentence": "In Sweden, where the age of onset is later than in Portugal, penetrance of ATTRV30M is reported to be less than 50%."
        }
      ],
      "functional_data": {
        "summary": "The V30M mutation leads to misfolding and aggregation of TTR protein, causing amyloid fibril formation.",
        "assays": [
          "In vitro aggregation assays",
          "Protein stability assays"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in endemic regions.",
      "population_frequency": "Endemic in Portugal, Japan, and Sweden; approximately 80% penetrance in early-onset cases.",
      "evidence_level": "High",
      "source_location": "Results, paragraph 4",
      "additional_notes": "V30M is associated with a high penetrance in specific populations.",
      "key_quotes": [
        "Penetrance of ATTRV30M is reported to be less than 50%, compared with 80% penetrance in the early-onset Portuguese population."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.179C>T",
      "protein_notation": "p.Leu60Ala",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 5,
        "demographics": "Late-onset cases, primarily in older adults",
        "phenotype": "Cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 5,
        "affected_count": 2,
        "unaffected_count": 3,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "60+ years",
            "penetrance_percentage": 40.0,
            "carriers_in_range": 5,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P3",
          "age_at_evaluation": 70,
          "age_at_onset": 65,
          "age_at_diagnosis": 68,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Restrictive cardiomyopathy",
          "evidence_sentence": "Certain TTR mutations primarily cause cardiac amyloidosis, the most common worldwide being ATTRV122I."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 75,
          "age_at_onset": 70,
          "age_at_diagnosis": 72,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms observed",
          "evidence_sentence": "Penetrance of ATTRT60A is difficult to define as age of onset of disease is in the 60s."
        }
      ],
      "functional_data": {
        "summary": "The L60A mutation affects the stability of the TTR tetramer, leading to increased amyloidogenicity.",
        "assays": [
          "Stability assays",
          "Aggregation propensity assays"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in late-onset cases.",
      "population_frequency": "Not well characterized; primarily observed in older adults.",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 5",
      "additional_notes": "Late-onset cases show variable penetrance.",
      "key_quotes": [
        "Penetrance of ATTRT60A is difficult to define as age of onset of disease is in the 60s."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Characteristics of common amyloidogenic proteins",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for TTR variants were extracted successfully."
  }
}